COVID-2019 vaccine(EpiVax/Immunomic Therapeutics/PharmaJet)

N/A

Report date: 2024/06/05 10:33:29

Base Information

Drug NameCOVID-2019 vaccine(EpiVax/Immunomic Therapeutics/PharmaJet)
Drug Alias NameOmicron Booster（PharmaJet）PharmaJet Tropis
ClassificationVaccines > Development/production technology > Nucleic acid vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Africa
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPharmajet IncImmunomic Therapeutics IncEpiVax Inc
China Registration ClassN/A

Develop Information

Active CompaniesScancell Ltd
Inactive CompaniesEpiVax IncPharmajet IncImmunomic Therapeutics Inc
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A